News
Important Only
Other
Dine Brands Global Announces Intention To Refinance Its Series 2019-1 Class A-2-Ii Fixed Rate Senior Secured Notes And Its Series 2022-1 Class A-1 Variable Funding Senior Notes Through A Securitization
May 27 (Reuters) - Dine Brands Global Inc DIN.N:DINE BRANDS GLOBAL, INC. ANNOUNCES INTENTION TO REFINANCE ITS SERIES 2019-1 CLASS A-2-II FIXED RATE SENIOR SECURED NOTES AND ITS SERIES 2022-1 CLASS A-1 VARIABLE FUNDING SENIOR NOTES THROUGH A SECURITIZATIONReuters
Tue, May 27
Other
Q2 Metals Expands Major Lithium Zone At The Cisco Lithium Project Hole 27 Drilled 179.6 Metres At 1.66% Li₂o, 58.0 Metres At 1.75% Li₂o, And 91.8 Metres At 1.81% Li₂o
May 27 (Reuters) - Q2 Metals Corp QTWO.V:Q2 METALS EXPANDS MAJOR LITHIUM ZONE AT THE CISCO LITHIUM PROJECT: HOLE 27 DRILLED 179.6 METRES AT 1.66% LI₂O, 58.0 METRES AT 1.75% LI₂O, AND 91.8 METRES AT 1.81% LI₂OReuters
Tue, May 27
Stocks
Rocket Pharma sinks after patient death, US FDA's clinical hold on gene therapy trial
** Shares of Rocket Pharmaceuticals RCKT.O plummet 64.11% to $2.25 premarket** Co says patient participating in mid-stage trial studying its experimental gene therapy, RP-A501, died after acute systemic infection** U.S. FDA last Friday placed clinical hold on trial to allow further evaluation** RCKT...Reuters
Tue, May 27
Other
See All Ai Raises $33 Mln To Bring Revolutionary Ai-Based Sliceable Intraoperative 3D Visualization And Advanced Navigation To Global Healthcare
May 27 (Reuters) - SEE ALL AI RAISES $33 MILLION TO BRING REVOLUTIONARY AI-BASED SLICEABLE INTRAOPERATIVE 3D VISUALIZATION AND ADVANCED NAVIGATION TO GLOBAL HEALTHCAREFurther company coverage: [ ]Reuters
Tue, May 27
Other
Ukrainian climber released from detention days after record-breaking Everest ascent
By Gopal Sharma KATHMANDU, May 27 (Reuters) - Ukrainian climber Andrew Ushakov, who completed a journey from sea level to the summit of Mount Everest in a record four days, has been released on bail following his arrest for carrying undeclared foreign currency, a Nepali official told Reuters on T...Reuters
Tue, May 27
Other
Rocket Pharmaceuticals Provides Update On Phase 2 Clinical Trial Of Rp-A501 For Danon Disease
May 27 (Reuters) - Rocket Pharmaceuticals Inc RCKT.O:ROCKET PHARMACEUTICALS PROVIDES UPDATE ON PHASE 2 CLINICAL TRIAL OF RP-A501 FOR DANON DISEASEROCKET PHARMACEUTICALS INC - IN ACTIVE DIALOGUE WITH FDA AFTER SAE IN RP-A501 TRIALROCKET PHARMACEUTICALS INC - FDA PLACES CLINICAL HOLD ON RP-A501 TRIAL ...Reuters
Tue, May 27
Other
Rein Therapeutics Announces First Patient Dosed In Renew Phase 2 Trial Of Lti-03 In Patients With Ipf
May 27 (Reuters) - REIN THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN RENEW PHASE 2 TRIAL OF LTI-03 IN PATIENTS WITH IPFREIN THERAPEUTICS INC: TOPLINE INTERIM DATA FROM RENEW IS EXPECTED IN FIRST HALF OF 2026Reuters
Tue, May 27
Other
Imaflex Q1 EPS CAD 0.01
May 27 (Reuters) - Imaflex Inc IFX.V:IMAFLEX Q1 EPS CAD 0.01IMAFLEX Q1 EBITDA CAD 2.123 MILLIONIMAFLEX Q1 NET INCOME CAD 264 THOUSANDIMAFLEX Q1 REVENUE CAD 28.923 MILLIONIMAFLEX Q1 GROSS PROFIT CAD 4.725 MILLIONIMAFLEX Q1 BASIC EPS CAD 0.01IMAFLEX Q1 GROSS MARGIN 16.3%Reuters
Tue, May 27
Other
REFILE-ANALYSIS-US climate pullback threatens planned debt-for-nature deals
US Development Finance Corporation support in questionAngola, Zambia swaps among those impacted, sources say Angola says DFC more open to a development-swap dealBy Marc Jones and Virginia Furness LONDON, May 22 (Reuters) - Billions of dollars of debt deals aimed at protecting vital ecosystems fro...Reuters
Tue, May 27
Other
FACTBOX-Foreign companies eye US expansion to lessen fallout from tariffs
May 27 (Reuters) - Some non-U.S. companies have said they are looking at expanding their presence or setting up shop in the United States to mitigate the impact of President Donald Trump's tariffs.Below are some of the plans flagged by those companies.BARRY CALLEBAUT BARN.SThe chocolate maker is...Reuters
Tue, May 27
Other
Ituran Announces New OEM Agreement With Stellantis In South America
May 27 (Reuters) - Ituran Location and Control Ltd ITRN.O:ITURAN ANNOUNCES NEW OEM AGREEMENT WITH STELLANTIS IN SOUTH AMERICAITURAN LOCATION AND CONTROL LTD - CONTRACT COVERS MULTIPLE COUNTRIES IN SOUTH AMERICA FOR MULTI-YEAR PERIODReuters
Tue, May 27
Other
Brainstorm Secures Key Manufacturing Partnership With Minaris For Upcoming Nurown Phase 3B Als Clinical Trials
May 27 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.O:BRAINSTORM SECURES KEY MANUFACTURING PARTNERSHIP WITH MINARIS FOR UPCOMING NUROWN® PHASE 3B ALS CLINICAL TRIALSReuters
Tue, May 27
